Inventors:
Kurt Osther - Scottsdale AZ, US
Assignee:
HumaCell, Inc. - Rochester NY
International Classification:
A61K 35/48, A61K 48/00, A61K 35/14, A61K 35/50, A61K 35/28, A61K 35/12
US Classification:
424 9321, 424 937, 514 44 R
Abstract:
Disclosed are methods and means for treatment of neurodegenerative disease. In particular, the methods entail administration of stem cells expressing genes encoding therapeutically effective amounts of Nrf2. Also disclosed is a gene-therapy method for treatment of neurodegenerative disease, where genes encoding Nrf2 are administered.